Impedimed Limited's market cap is currently ―. The company's EPS TTM is AU$-0.01; its P/E ratio is -8.82; Impedimed Limited is scheduled to report earnings on February 26, 2024, and the estimated EPS forecast is AU

gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 22	Jun 21	Jun 20	Jun 19	Jun 18
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	AU$ 40.73M	AU$ 19.68M	AU$ 19.66M	AU$ 11.33M	AU$ 31.34M
Total Assets	AU$ 58.70M	AU$ 34.20M	AU$ 33.06M	AU$ 22.58M	AU$ 41.77M
Total Debt	AU$ 170.00K	AU$ 474.00K	AU$ 871.00K	AU$ 0.00	AU$ 0.00
Net Debt	AU$ -40.56M	AU$ -19.21M	AU$ -18.79M	AU$ -11.33M	AU$ -31.34M
Total Liabilities	AU$ 7.66M	AU$ 8.69M	AU$ 5.70M	AU$ 6.80M	AU$ 5.76M
Stockholders Equity	AU$ 51.04M	AU$ 25.51M	AU$ 27.36M	AU$ 15.79M	AU$ 36.00M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in AUD

Impedimed Limited Earnings and Revenue History

Income Statement >

Impedimed Limited Debt to Assets

Balance Sheet >

Impedimed Limited Cash Flow

Cash Flow >

Impedimed Limited Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing